يعرض 1 - 10 نتائج من 97 نتيجة بحث عن '"Vídriales, María-Belén"', وقت الاستعلام: 0.81s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

    المؤلفون: Martínez-Cuadrón, David, Megías-Vericat, Juan E., Gil, Cristina, Bernal, Teresa, Tormo, Mar, Martínez-Sánchez, Pilar, Rodríguez-Medina, Carlos, Serrano, Josefina, Herrera, Pilar, Pérez-Simón, José A., Sayas, María-José, Bergua, Juan, Lavilla, Esperanza, Amigo, María Luz, Benavente, Celina, López-Lorenzo, José L., Pérez-Encinas, Manuel, Vidriales, Maria Belén, Colorado, Mercedes, Rueda, Beatriz de, García-Boyero, Raimundo, Marini, Sandra, García-Suárez, Julio, López-Pavía, María, Gómez-Roncero, María Isabel, Noriega, Víctor, López, Aurelio, Labrador, Jorge, Cabello, Ana, Sossa, Claudia, Algarra, Lorenzo, Stevenazzi, Mariana, Solana-Altabella, Antonio, Boluda, Blanca, Montesinos, Pau

    المساهمون: Instituto de Salud Carlos III, European Commission, Pérez-Simón, José A., Consejo Superior de Investigaciones Científicas https://ror.org/02gfc7t72Test

    وصف الملف: application/pdf

    العلاقة: Publisher's version; https://doi.org/10.3324/haematol.2022.282506Test; Sí; Haematologica 109(1): 115-128 (2024); http://hdl.handle.net/10261/360436Test

    الإتاحة: https://doi.org/10.3324/haematol.2022.282506Test
    http://hdl.handle.net/10261/360436Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML

    المؤلفون: Montesinos, Pau, Rodríguez-Veiga, Rebeca, Bergua Burgues, Juan Miguel, Algarra, Lorenzo, Botella, Carmen, Josè Antonio, Perez Simon, Bernal, Teresa, Tormo, Mar, Robles, Maria Calbacho, Salamero, Olga, Serrano, Josefina, Noriega, Victor, López-López, Juan Antonio, Polo, Susana Vives, Colorado, Mercedes, Lorenzo, Jose Luis Lopez, Vidriales, María Belén, Boyero, Raimundo Garcia, Olave, Mayte, Herrera-Puente, Pilar, Arce, Olga, Garcia, Manuel Barrios, Jose Sayas Lloris, Maria, Polo, Marta, Isabel Gomez Roncero, Maria, Barragan, Eva, Ayala Diaz, Rosa, Carmen Chillon, Maria, Jose Calasanz, Maria, Boluda, Blanca, Martinez-Cuadrón, David, Labrador, Jorge

    المصدر: HemaSphere ; volume 7, issue S3, page e734771d ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000967432.73477.1dTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells

    المؤلفون: Muntión, Sandra, Preciado, Silvia, Sánchez-Luis, Elena, Corchete, Luis A., Díez-Campelo, María, Osugui, Lika, Martí-Chillón, Gerardo-Javier, Vidriales, Maria Belén, Navarro-Bailón, Almudena, Rivas, Javier de las, Sánchez-Guijo, Fermín M.

    المساهمون: Novartis, Fundacion de la Sociedad Española de Hematología y Hemoterapia, Instituto de Salud Carlos III, European Commission, Ministerio de Ciencia e Innovación (España)

    مصطلحات موضوعية: Aplasia, Eltrombopag, Hematopoiesis, Mesenchymal stem cells, MSC

    وصف الملف: application/pdf

    العلاقة: Publisher's version; http://dx.doi.org/10.1177/20406207221142137Test; Sí; e-issn: 2040-6215; Therapeutic Advances in Hematology 13: 1-13 (2022); http://hdl.handle.net/10261/296597Test

    الإتاحة: https://doi.org/10.1177/20406207221142137Test
    http://hdl.handle.net/10261/296597Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Characteristics and outcomes of adult patients in the PETHEMA registry with relapsed or refractory FLT3-ITD mutation-positive acute myeloid leukemia

    المؤلفون: Martínez-Cuadrón, David, Serrano, Josefina, Mariz, José, Gil, Cristina, Tormo, Mar, Martínez-Sánchez, Pilar, Rodríguez-Arbolí, Eduardo, García-Boyero, Raimundo, Rodríguez-Medina, Carlos, Martínez-Chamorro, Carmen, Polo, Marta, Bergua, Juan, Aguiar, Eliana, Amigo, María Luz, Herrera, Pilar, Alonso-Domínguez, Juan Manuel, Bernal, T., Espadana, Ana, Sayas, María-José, Algarra, Lorenzo, Vidriales, Maria Belén, Vasconcelos, Graça, Vives, Susana, Pérez-Encinas, Manuel, López, Aurelio, Noriega, Víctor, García-Fortes, María, Chillón, M. del Carmen, López, Juan A., Boluda, Blanca, Rodríguez-Veiga, Rebeca, Martínez-López, Joaquín, Barragán, Eva, Sanz, Miguel Ángel, Montesinos, Pau

    المساهمون: Centro de Investigación Biomédica en Red Cáncer (España)

    مصطلحات موضوعية: Acute myeloid leukemia, FLT3-ITD mutation, Real-world outcomes, Relapsed/refractory disease, Salvage therapy

    العلاقة: Publisher's version; http://dx.doi.org/10.3390/cancers14112817Test; Sí; e-issn: 2072-6694; Cancers 14(11): 2817 (2022); http://hdl.handle.net/10261/288789Test

    الإتاحة: https://doi.org/10.3390/cancers14112817Test
    http://hdl.handle.net/10261/288789Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

    المؤلفون: Ayala, Rosa, Rapado, Inmaculada, Onecha, Esther, Martínez-Cuadrón, David, Carreño-Tarragona, Gonzalo, Bergua Burgues, Juan Miguel, Vives Polo, Susana, Algarra Algarra, Jesus Lorenzo, Tormo, Mar, Martinez, Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, Gil, Cristina, López Lorenzo, Jose Luis, Vidriales, María Belén, Labrador, Jorge, Falantes, José Francisco, Sayas, María José, Paiva, Bruno, Barragán, Eva, Prosper, Felipe, Sanz, Miguel A., Martínez-López, Joaquín, Montesinos, Pau, Universitat Autònoma de Barcelona

    مصطلحات موضوعية: Clinical trials and observations, Myeloid neoplasia, NGS, Variants, Leukemia, Myelocytic, Acute, Leukemic cells, Older adults, Genetic risk, Complete remission, Cytarabine, Azacytidine, Prognostic factors

    وصف الملف: application/pdf

    العلاقة: Ministerio de Economía y Competitividad CB16/12/00369; Ministerio de Economía y Competitividad PI16/01530; Ministerio de Economía y Competitividad PI16/01661; Instituto de Salud Carlos III PI19/01518; Instituto de Salud Carlos III PI19/00730; Cancers; Vol. 13 (may 2021); https://ddd.uab.cat/record/255656Test; urn:10.3390/cancers13102458; urn:oai:ddd.uab.cat:255656; urn:pmcid:PMC8158477; urn:pmc-uid:8158477; urn:oai:pubmedcentral.nih.gov:8158477; urn:pmid:34070172

    الإتاحة: https://ddd.uab.cat/record/255656Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.

    المؤلفون: Simoes, Catia, Paiva, Bruno, Martínez-Cuadrón, David, Bergua, Juan-Miguel, Vives, Susana, Algarra, Lorenzo, Tormo, Mar, Martinez, Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, Gil, Cristina, Lopez, Jose-Luis, Vidriales, Maria-Belen, Labrador, Jorge, Falantes, Jose-Francisco, Sayas, María-José, Ayala, Rosa, Martinez-Lopez, Joaquin, Villar, Sara, Calasanz, Maria-Jose, Prosper, Felipe, San-Miguel, Jesús F, Sanz, Miguel Ángel, Montesinos, Pau

    مصطلحات موضوعية: Aged, Cytarabine, Humans, Leukemia, Myeloid, Acute, Neoplasm, Residual, Prognosis, Remission Induction

    العلاقة: http://hdl.handle.net/10668/17127Test; PMC7876892; https://ashpublications.org/bloodadvances/article-pdf/5/3/760/1799446/advancesadv2020003195.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876892/pdfTest

    الإتاحة: https://doi.org/10.1182/bloodadvances.2020003195Test
    http://hdl.handle.net/10668/17127Test
    https://ashpublications.org/bloodadvances/article-pdf/5/3/760/1799446/advancesadv2020003195.pdfTest
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876892/pdfTest

    View record in BASE النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    المؤلفون: Castaño-Bonilla, Tamara, Alonso-Domínguez, Juan M., Barragán, Eva, Rodríguez-Veiga, Rebeca, Sargas, Claudia, Gil, Cristina, Chillón, Carmen, Vidriales, Maria Belén, García, Raimundo, Martínez-López, Joaquín, Ayala, Rosa, Larrayoz, María J., Anguita, Eduardo, Cuello, Rebeca, Cantalapiedra, Alberto, Carrillo Cruz, Estrella, Soria-Saldise, Elena, Labrador, Jorge, Recio, Isabel, Algarra, Lorenzo, Rodríguez-Medina, Carlos, Bilbao-Syeiro, Cristina, López-López, Juan A., Serrano, Josefina, Cabo, Erik de, Sayas, María-José, Olave, María-Teresa, Sanchez-Garcia, Joaquin, Mateos, Mamen, Blas, Carlos, López-Lorenzo, José L., Lainez-González, Daniel, Serrano, Juana, Martínez-Cuadrón, David, Sanz, Miguel Ángel, Montesinos, Pau

    العلاقة: Publisher's version; http://dx.doi.org/10.1038/s41598-021-00050-xTest; Sí; e-issn: 2045-2322; Scientific Reports 11: 20745 (2021); http://hdl.handle.net/10261/261366Test

    الإتاحة: https://doi.org/10.1038/s41598-021-00050-xTest
    http://hdl.handle.net/10261/261366Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

    المؤلفون: Paiva, Bruno, Puig, Noemi, Cedena, Maria-Teresa, Rosiñol, Laura, Cordón, Lourdes, Vidriales, Maria Belén, Burgos, Leire, Flores-Montero, Juan, Sanoja-Flores, Luzalba, López-Anglada, Lucía, Maldonado, Roberto, Cruz, Javier de la, Gutiérrez, Norma Carmen, Calasanz, Mª Jose, Martín-Ramos, María-Luisa, García-Sanz, Ramón, Martínez-López, Joaquín, Oriol, Albert, Blanchard, María Jesús, Ríos, Rafael, Martín, Jesús, Martínez-Martínez, Rafael, Sureda, Anna, Hernandez, Miguel T., Rubia, Javier de la, Krsnik, Isabel, Moraleda, José María, Palomera, Luis, Bargay, Joan

    المساهمون: Celgene, Janssen Biotech, Sanofi, Takeda Pharmaceutical Company, Amgen, Gilead Sciences, Incyte, Bristol-Myers Squibb, Prothena, Pfizer

    العلاقة: Publisher's version; http://doi.org/10.1200/JCO.19.01231Test; Sí; e-issn: 1527-7755; Journal of Clinical Oncology 38(8): 784-792 (2020); http://hdl.handle.net/10261/236164Test; http://dx.doi.org/10.13039/100006436Test; http://dx.doi.org/10.13039/100002429Test; http://dx.doi.org/10.13039/100002491Test; http://dx.doi.org/10.13039/100005564Test; http://dx.doi.org/10.13039/100005565Test; http://dx.doi.org/10.13039/100004319Test; http://dx.doi.org/10.13039/100004339Test; http://dx.doi.org/10.13039/100008373Test

    الإتاحة: https://doi.org/10.1200/JCO.19.01231Test
    https://doi.org/10.13039/100006436Test
    https://doi.org/10.13039/100002429Test
    https://doi.org/10.13039/100002491Test
    https://doi.org/10.13039/100005564Test
    https://doi.org/10.13039/100005565Test
    https://doi.org/10.13039/100004319Test
    https://doi.org/10.13039/100004339Test
    https://doi.org/10.13039/100008373Test
    http://hdl.handle.net/10261/236164Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large B-cell lymphoma

    المؤلفون: Alonso-Álvarez, Sara, Alcoceba, Miguel, García-Alvarez, María, Blanco, Óscar, Rodríguez, Marta, Baile, Mónica, Caballero, Juan-Carlos, Dávila, Julio, Vidriales, Maria Belén, Esteban, Carmen, Arias, Piedad, Díaz, Luis G., Tamayo, Pilar, Caballero, Maria Dolores, Gutiérrez, Norma Carmen, González, Marcos, Martín, Alejandro

    المساهمون: Instituto de Salud Carlos III, Junta de Castilla y León, European Commission, Gilead Sciences, Ministerio de Economía y Competitividad (España)

    مصطلحات موضوعية: Bone marrow involvement, Diffuse large B-cell lymphoma, Discordant bone marrow, Concordant bone marrow

    العلاقة: Publisher's version; https://doi.org/10.3390/cancers12020474Test; Sí; Cancers 12(2): 474 (2020); http://hdl.handle.net/10261/222745Test; http://dx.doi.org/10.13039/501100003329Test; http://dx.doi.org/10.13039/501100004587Test; http://dx.doi.org/10.13039/100005564Test; http://dx.doi.org/10.13039/501100000780Test; http://dx.doi.org/10.13039/501100014180Test

    الإتاحة: https://doi.org/10.3390/cancers12020474Test
    https://doi.org/10.13039/501100003329Test
    https://doi.org/10.13039/501100004587Test
    https://doi.org/10.13039/100005564Test
    https://doi.org/10.13039/501100000780Test
    https://doi.org/10.13039/501100014180Test
    http://hdl.handle.net/10261/222745Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Measures to maintain a SARS-CoV-2 negative inpatient hematological unit in the midst of the COVID-19 pandemic

    المؤلفون: Cabero-Martínez, Almudena, Sánchez-Guijo, Fermín M., López-Corral, L., Pérez-López, Estefanía, Avendaño, Alejandro, Baile, Mónica, Cabrero, Mónica, Martín, Ana-África, Rodríguez, Ángela, Pérez, Balbina, Peña-Muñoz, Felipe, Román, Luz-Gema, Palomino, Danylo, López-Vázquez, Lourdes, Vidriales, Maria Belén, González, Marcos, Mateos, Maria Victoria, Caballero, Maria Dolores

    مصطلحات موضوعية: COVID-19, Hematology, Preventive measurements, Inpatient units, Immunodepressed patients, Pandemic

    العلاقة: Publisher's version; https://doi.org/10.3389/fmed.2020.00462Test; Sí; Frontiers in Medicine 7: 462 (2020); http://hdl.handle.net/10261/220785Test

    الإتاحة: https://doi.org/10.3389/fmed.2020.00462Test
    http://hdl.handle.net/10261/220785Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث